Apogee Therapeutics | 8-K: Current report
Apogee Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Apogee Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Apogee Therapeutics | 8-K: Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results
Apogee Therapeutics | 8-K: Current report
Apogee Therapeutics | DEFA14A: Others
Apogee Therapeutics | 8-K: Current report
Apogee Therapeutics | 8-K: Current report
Apogee Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Apogee Therapeutics | 8-K: Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results
Apogee Therapeutics | DEF 14A: Definitive information statements
Apogee Therapeutics | DEFA14A: Others
Apogee Therapeutics | 8-K: Current report
Apogee Therapeutics | S-1MEF: A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S 1
Apogee Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Apogee Therapeutics | 8-K: Current report
Apogee Therapeutics | 8-K: Apogee Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
Apogee Therapeutics | 8-K: Apogee Highlights Corporate Progress and Reports Third Quarter 2023 Financial Results
Apogee Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Apogee Therapeutics | 8-K: Apogee Highlights Corporate Progress and Reports Second Quarter 2023 Financial Results
No Data
No Data